Cargando…

Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease

Detalles Bibliográficos
Autor principal: Lott, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822371/
https://www.ncbi.nlm.nih.gov/pubmed/32648429
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09
_version_ 1783639620046553088
author Lott, Felipe
author_facet Lott, Felipe
author_sort Lott, Felipe
collection PubMed
description
format Online
Article
Text
id pubmed-7822371
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-78223712021-01-23 Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease Lott, Felipe Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2020-07-31 /pmc/articles/PMC7822371/ /pubmed/32648429 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Update in Urology
Lott, Felipe
Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title_full Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title_fullStr Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title_full_unstemmed Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title_short Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
title_sort editorial comment: cardiovascular morbidity in a randomized trial comparing gnrh agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease
topic Update in Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822371/
https://www.ncbi.nlm.nih.gov/pubmed/32648429
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09
work_keys_str_mv AT lottfelipe editorialcommentcardiovascularmorbidityinarandomizedtrialcomparinggnrhagonistandgnrhantagonistamongpatientswithadvancedprostatecancerandpreexistingcardiovasculardisease